Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 24
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
International validation of harmonized definitions for complications of blood donations | Land KJ, Townsend M, Goldman M, Whitaker BI, Perez GE, Wiersum-Osselton JC | 2018 | Transfusion | View International validation of harmonized definitions for complications of blood donations | Blood operators | New or improved product or process |
Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Wan H, Wang Y, Ai J, Brathwaite S, Ni H, Macdonald RL, Hol EM, Meijers JCM, Vergouwen MDI | 2018 | J Thromb Haemost | View Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Researchers | Basic research |
Targeted recruitment of male donors for allogeneic haematopoietic cell transplantation: A review of the evidence | Fingrut W, Rikhraj K, Allan D | 2018 | Vox Sang | View Targeted recruitment of male donors for allogeneic haematopoietic cell transplantation: A review of the evidence | Blood operators | Clinical research |
Modeling rare blood in Canada | Blake JT, Clarke G | 2018 | Transfusion | View Modeling rare blood in Canada | Health care providers | New or improved product or process |
Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | de Souza LR, Scott BM, Bhakta V, Donkor DA, Perruzza DL, Sheffield WP | 2018 | Serpins: Methods and Protocols | View Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | Researchers | Other |
Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Health care providers | Benchmarking and standard setting |
Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials | Linkins L, Hu G, Warkentin TE | 2018 | Res Pract Thromb Haemost | View Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials | Researchers | Clinical research |
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Sheffield WP, Eltringham-Smith LJ, Bhakta V | 2018 | BMC Biotechnol | View A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Researchers | Basic research |
Erythrocyte saturation with IgG is required for inducing antibody-mediated immune suppression and impacts both erythrocyte clearance and antigen-modulation mechanisms | Cruz-Leal Y, Marjoram D, Lazarus AH | 2018 | J Immunol | View Erythrocyte saturation with IgG is required for inducing antibody-mediated immune suppression and impacts both erythrocyte clearance and antigen-modulation mechanisms | Researchers | Basic research |
Fusion to human serum albumin extends the circulatory half-life and duration of antithrombotic action of the Kunitz protease inhibitor domain of Protease Nexin 2 | Sheffield WP, Eltringham-Smith LJ, Bhakta V | 2018 | Cell Physiol Biochem | View Fusion to human serum albumin extends the circulatory half-life and duration of antithrombotic action of the Kunitz protease inhibitor domain of Protease Nexin 2 | Researchers | Basic research |
Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG | 2018 | J Thromb Haemost | View Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Health care providers | Basic research |
The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Kavsak PA, Ainsworth C, Arnold DM, Scott T, Clark L, Ivica J, Mackett K, Whitlock R, Worster A | 2018 | Clin Biochem | View The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Researchers | Basic research |
Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Nagao M, Sengupta J, Diaz-Dussan D, Adam M, Wu M, Acker J, Ben R, Ishihara K, Zeng H, Miura Y, Narain R | 2018 | ACS Appl Bio Mater | View Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Researchers | Basic research |
Chloride and other electrolyte concentrations in commonly available 5% albumin products | Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B | 2018 | Crit Care Med | View Chloride and other electrolyte concentrations in commonly available 5% albumin products | Researchers | Clinical research |
Screening of red blood cells for extracellular vesicle content as a product quality indicator | Acker JP, Almizraq RJ, Millar D, Maurer-Spurej E | 2018 | Transfusion | View Screening of red blood cells for extracellular vesicle content as a product quality indicator | Researchers | New or improved product or process |
Anti-M (French) | Clarke G, Cote J, Lane D | 2018 | Blood.ca website | View Anti-M (French) | Researchers | Basic research |
Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Langlois GP, Arnold DM, Potts J, Leber B, Dale DC, Mackey MC | 2018 | Clin Case Rep | View Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Health care providers | Clinical research |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Qu M, Liu Q, Zhao H-G, Peng J, Ni H, Hou M, Jansen AJG | 2018 | Ann Hematol | View Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Health care providers | Clinical research |
A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy | Dyer C, Alquist CR, Cole-Sinclair M, Curnow E, Dunbar NM, Estcourt LJ, Kaufman R, Kutner JM, McCullough J, McQuilten Z, Potiphar L, Rioux-Masse B, Slichter S, Tinmouth A, Webert K, Yokoyama AP, Stanworth SJ | 2018 | Vox Sang | View A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy | Health care providers | Clinical research |
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |
ResearchUnit: A model for change: predicting the impact of system-wide improvements | Blake J | 2018 | Blood.ca website | View ResearchUnit: A model for change: predicting the impact of system-wide improvements | Other | New or improved product or process |
ResearchUnit: Patient blood group impacts susceptibility to IVIg-associated hemolysis | Branch D | 2018 | Blood.ca website | View ResearchUnit: Patient blood group impacts susceptibility to IVIg-associated hemolysis | Researchers | Basic research |
A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Del Fiol G MM, Iorio A, Cotoi C, Haynes RB | 2018 | J Med Internet Res | View A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Researchers | Clinical research |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Aphérèse thérapeutique | Pavenski K | 2018 | Guide de la pratique transfusionnelle | View Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies | Shih AW, Liu A, Elsharawi R, Crowther MA, Cook RJ, Heddle NM | 2018 | Transfusion | View Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies | Researchers | Clinical research |
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Wong PPC, Kariminia A, Jones D, Eaves CJ, Foley R, Ivison S, Couban S, Schultz KR | 2018 | Blood | View Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Health care providers | Clinical research |
Changes in plasma unit distributions to hospitals over a 10-year period | Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Kamel H, Karafin M, Kelting N, Lewis M, O'Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titlestad K, Yazer MH | 2018 | Transfusion | View Changes in plasma unit distributions to hospitals over a 10-year period | Blood operators | Clinical research |
Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire | Chai-Adisaksopha C, Skinner MW, Curtis R, Frick N, Nichol MB, Noone D, O'Mahony B, Page D, Stonebraker J, Thabane L, Crowther M, Iorio A | 2018 | BMJ Open | View Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire | Researchers | Clinical research |
Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia | Guo L, Kapur R, Aslam R, Hunt K, Hou Y, Zufferey A, Speck ER, Rondina MT, Lazarus AH, Ni H, Semple JW | 2018 | Scand J Immunol | View Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia | Researchers | Basic research |
How do we diagnose immune thrombocytopenia in 2018? | Kelton JG VJ, Arnold DM | 2018 | Hematology Am Soc Hematol Educ Program | View How do we diagnose immune thrombocytopenia in 2018? | Health care providers | Clinical research |
Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes | Pierce GF, Iorio A | 2018 | Haemophilia | View Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes | Health care providers | New or improved product or process |
Concurrence of symmetrical peripheral gangrene and venous limb gangrene following polytrauma: a case report | Tan JH, Mohamad Y, Tan CLH, Kassim M, Warkentin TE | 2018 | J Med Case Rep | View Concurrence of symmetrical peripheral gangrene and venous limb gangrene following polytrauma: a case report | Health care providers | Clinical research |
Does my complex patient have DIC? | Shih A | 2018 | CanadiEM website | View Does my complex patient have DIC? | Health care providers | Other |
IgA deficiency | Goldman M | 2018 | Blood.ca website | View IgA deficiency | Health care providers | Benchmarking and standard setting |
The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis | Montroy J, Hutton B, Moodley P, Fergusson NA, Cheng W, Tinmouth A, Lavallee LT, Fergusson DA, Breau RH | 2018 | Transfus Med Rev | View The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis | Researchers | Clinical research |
Transfusion requirements in cardiac surgery III (TRICS III): study design of a randomized controlled trial | Shehata N, Whitlock R, Fergusson DA, Thorpe KE, MacAdams C, Grocott HP, Rubens F, Fremes S, Lellouche F, Bagshaw S, Royse A, Rosseel PM, Hare G, Medicis E, Hudson C, Belley-Cote E, Bainbridge D, Kent B, Shaw A, Byrne K, Syed S, Royse CF, McGuiness S, Hall J, Mazer CD | 2018 | J Cardiothorac Vasc Anesth | View Transfusion requirements in cardiac surgery III (TRICS III): study design of a randomized controlled trial | Researchers | Clinical research |
Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Lieberman L, Lin Y, Cserti-Gazdewich C, Yi QL, Pendergrast J, Lau W, Callum J | 2018 | Pediatr Blood Cancer | View Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Health care providers | Clinical research |
Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates | Alabdullatif M, Atreya CD, Ramirez-Arcos S | 2018 | Transfusion | View Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates | Researchers | New or improved product or process |
La maladie hémolytique du foetus et du nouveau-né et thrombopénie immune périnatale | Clarke G, Hannon J | 2018 | Guide de la pratique transfusionnelle | View La maladie hémolytique du foetus et du nouveau-né et thrombopénie immune périnatale | Health care providers | Other |
ResearchUnit: How does anti-D prevent hemolytic disease of the fetus and newborn? Lessons from a mouse model | Lazarus A | 2018 | Blood.ca website | View ResearchUnit: How does anti-D prevent hemolytic disease of the fetus and newborn? Lessons from a mouse model | Other | Other |
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Ragni MV, Croteau SE, Morfini M, Cnossen MH, Iorio A | 2018 | J Thromb Haemost | View Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Health care providers | Basic research |
Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Warkentin TE | 2018 | J Thromb Haemost | View Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Health care providers | Benchmarking and standard setting |
Exploring donor and product factors and their impact on red cell post-transfusion outcomes | Ning S, Heddle NM, Acker JP | 2018 | Transfus Med Rev | View Exploring donor and product factors and their impact on red cell post-transfusion outcomes | Health care providers | Clinical research |
Modeling the optimal ethnic composition of an adult stem cell registry | Blake JT, McTaggart K, Killeen D | 2018 | Eur J Oper Res | View Modeling the optimal ethnic composition of an adult stem cell registry | Blood operators | New or improved product or process |
Concentré de recherche: Rôle du groupe sanguin dans le déclenchement d'une hémolyse après l'administration d'immunoglobulines | Branch D | 2018 | Blood.ca website | View Concentré de recherche: Rôle du groupe sanguin dans le déclenchement d'une hémolyse après l'administration d'immunoglobulines | Researchers | Basic research |
Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Devine DV | 2018 | JAMA Oncol | View Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Researchers | New or improved product or process |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Plasma components | Health care providers | Benchmarking and standard setting |
Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | MacIsaac J, Siddiqui R, Jamula E, Li N, Baker S, Webert KE, Evanovitch D, Heddle NM, Arnold DM | 2018 | Transfusion | View Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | Researchers | Clinical research |
Therapeutic Apheresis | Pavenski K | 2018 | Clinical Guide to Transfusion | View Therapeutic Apheresis | Health care providers | Benchmarking and standard setting |